Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus (LUCID)

This study is currently recruiting participants.
Verified June 2012 by DexCom, Inc.
Sponsor:
Information provided by (Responsible Party):
DexCom, Inc.
ClinicalTrials.gov Identifier:
NCT01627184
First received: June 21, 2012
Last updated: June 22, 2012
Last verified: June 2012

June 21, 2012
June 22, 2012
May 2012
Not Provided
Glycemic Control during Exercise [ Designated as safety issue: No ]
The proportion of time spent in euglycemia zone as well as hypoglycemia zone will be determined from the system glucose readings, particularly during subject's high levels of activity. Longitudinal data analysis methods will be used to assess the within-subject and between-subject effects of the glycemic control for the study population.
Same as current
Complete list of historical versions of study NCT01627184 on ClinicalTrials.gov Archive Site
System Utility and Usability [ Designated as safety issue: No ]

The objectives of the study are to evaluate the Dexcom G4 system utility and usability during high levels of activity and home use. The assessments may be evaluated by, but are not limited to, the following:

  • Number and duration of sensors used by subject
  • Percentage of CGM system communication during wear
  • Percentage of CGM system glucose reading during wear
  • Incidence of System prompts and error messages recorded in the receiver
Same as current
Not Provided
Not Provided
 
Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus
Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus

The purpose of this study is to evaluate CGM glycemic control using the Dexcom G4 system as well as system performance during high levels of activity and home use by adult athletes with insulin-requiring diabetes mellitus, over an extended period of time.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Adult athletes with diabetes mellitus

Diabetes Mellitus
Device: Dexcom G4 CGM System
Athletes with diabetes mellitus
Intervention: Device: Dexcom G4 CGM System
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
15
May 2013
Not Provided

Inclusion Criteria:

  1. Age 18 years or older
  2. Diagnosis of diabetes mellitus

Exclusion Criteria:

  1. Extensive skin changes/diseases
  2. Known allergy to medical adhesives
  3. Pregnancy
  4. Dialysis
Both
18 Years and older
Not Provided
Contact: Katie Gazaway (404) 419-9815 kgazaway@atlantadiabetes.com
United States
 
NCT01627184
PTL-900905
No
DexCom, Inc.
DexCom, Inc.
Not Provided
Not Provided
DexCom, Inc.
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP